Skip to main content

Advertisement

SpringerLink
Log in

Letter to the Editor: Reply

  • Reply, Letter to the Editor
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bothra S, Chekavar A, Mayilvaganan S (2017) Prognostic significance of the proportion of tall cell components in papillary thyroid carcinoma. World J Surg. doi:10.1007/s00268-017-3945-3

    Google Scholar 

  2. Choi YJ, Shin JH, Kim JH, Jung SL, Son EJ, Oh YL (2011) Tall cell variant of papillary thyroid carcinoma: sonographic and clinical findings. J Ultrasound Med 30:853–858

    Article  PubMed  Google Scholar 

  3. Suzuki A, Hirokawa M, Higuchi M et al (2015) Cytological characteristics of papillary thyroid carcinoma on LBC specimens, compared with conventional specimens. Diagn Cytopathol 43:108–113

    Article  PubMed  Google Scholar 

  4. Lee SH, Jung CK, Bae JS, Jung SL, Choi YJ, Kang CS (2014) Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma. Diagn Cytopathol 42:11–17

    Article  PubMed  Google Scholar 

  5. Ito Y, Yoshida H, Maruo R et al (2009) BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J 56:89–97

    Article  CAS  PubMed  Google Scholar 

  6. Ito Y, Yoshida H, Kihara M, Kobayashi K, Miya A, Miyauchi A (2014) BRAF (V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients? World J Surg 38:679–687. doi:10.1007/s00268-013-2223-2

    Article  PubMed  Google Scholar 

  7. Matsuse M, Yabuta T, Saenko V et al (2017) TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors. Sci Rep 7:41752. doi:10.1038/srep41752

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ito Y, Hirokawa M, Miyauchi A, Higashiyama T, Kihara M, Miya A (2017) Prognostic significance of the proportion of tall cell components in papillary thyroid carcinoma. World J Surg 41:742–747. doi:10.1007/s00268-016-3784-7

    Article  PubMed  Google Scholar 

  9. Miyauchi A, Kudo T, Miya A et al (2011) Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 21:707–716

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe, Hyogo, 650-0011, Japan

    Yasuhiro Ito & Akira Miyauchi

  2. Department of Pathology, Kuma Hospital, Kobe, Japan

    Mitsuyoshi Hirokawa

Authors
  1. Yasuhiro Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akira Miyauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mitsuyoshi Hirokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuhiro Ito.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, Y., Miyauchi, A. & Hirokawa, M. Letter to the Editor: Reply. World J Surg 41, 2645–2646 (2017). https://doi.org/10.1007/s00268-017-3995-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-017-3995-6

Keywords

Search

Navigation